Derniers essais

EudraCT Number: 2006-003934-14

Sponsor Protocol Number: 86,1,2006_06_01

Start Date:

Sponsor Name: Universitätsmedizin Göttingen

Full Title: „Eine randomisierte, placebokontrollierte Doppelblindstudie zur Evaluation der Effektivität oral verabreichten Doxycyclins bei Patienten mit Creutzfeldt-Jakob-Krankheit“

Medical condition: Creutzfeldt-Jakob-Krankheit

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.0	10021881 - Infections and infestations	10055172	Creutzfeld-Jakob disease	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: (No results available)

EudraCT Number: 2004-004443-22

Sponsor Protocol Number: Spirig I 04-05

Start Date:

Sponsor Name: Spirig Pharma AG

Full Title: Untersuchung der Wirksamkeit einer glycerinhaltigen Creme bei der Behandlung von Atopischer Dermatitis. Kontrolliert, randomisierte Doppel-Blind-Studie.

Medical condition: Atopic Dermatitis

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.0		10012438

Population Age: Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: (No results available)

EudraCT Number: 2017-001550-34

Sponsor Protocol Number: TIGEM2-PDH

Start Date:

Sponsor Name: FONDAZIONE TELETHON

Full Title: Studio clinico pilota per valutare l’efficacia della terapia con fenilbutirrato in pazienti affetti da deficit di piruvato deidrogenasi

Medical condition: La Sperimentazione verrà eseguita su pazienti affetti da difetto dell’enzima piruvato deidrogenasi.I pazienti affetti da questa malattia manifestano aumento dei livelli di lattato nel sangue e nell...

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10027433 - Metabolism and nutrition disorders	10058097	Metabolic disorder	PT
	20.1	10027433 - Metabolism and nutrition disorders	10000491	Acidosis lactic	LLT
	20.0	10022891 - Investigations	10037677	Pyruvate	LLT
	20.0	10022891 - Investigations	10023660	Lactate increased	LLT
20.0	10022891 - Investigations	10057975	Lactate pyruvate ratio	PT

Population Age: Infants and toddlers, Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2018-003199-10

Sponsor Protocol Number: OLE-NLRC4/XIAP.2016.001

Start Date:

Sponsor Name: AB2 Bio Ltd.

Full Title: Open-label extension study with Tadekinig alfa (r-hIL-18BP) to monitor safety and tolerability in patients with IL-18 driven monogenic autoinflammatory conditions: NLRC4 mutation and XIAP deficiency

Medical condition: NLRC4 mutation XIAP deficiency

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: DE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2012-000856-33

Sponsor Protocol Number: 2012-40

Start Date:

Sponsor Name: Institut Pasteur

Full Title: A phase I/II, open-label, study of intracerebral administration of adeno-associated viral vector containing the human alpha-N-acetylglucosaminidase cDNA in children with Sanfilippo type B syndrome

Medical condition: Mucopolysaccharidosis III B

Disease:	Version	SOC Term	Classification Code	Term	Level
	17.0	10010331 - Congenital, familial and genetic disorders	10056890	Mucopolysaccharidosis III	PT

Population Age: Infants and toddlers, Children, Under 18

Gender: Male, Female

Trial protocol: FR (Completed)

Trial results: View results

EudraCT Number: 2010-021474-11

Sponsor Protocol Number: GE-001-013

Start Date:

Sponsor Name: GE Healthcare Ltd. and its Affiliates

Full Title: A Multicentre, Randomised, Open-label, Comparative Phase IV Trial To Assess Changes in Dementia Diagnostic Category and Diagnostic Confidence After DaTSCAN Imaging in Subjects with an Uncertain Dia...

Medical condition: Subjects with possible Dementia with Lewy Bodies (DLB) who may or may not also fulfil the criteria for Alzheimers Disease (AD)

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) ES (Ongoing) IT (Completed)

Trial results: View results

EudraCT Number: 2004-001653-28

Sponsor Protocol Number: 03/314

Start Date:

Sponsor Name: The Leeds teaching Hospitals NHS trust

Full Title: A comparison of the effects on prostaglandin synthesis and cytokine production of an olive-oil based lipid emulsion (Clinoloeic) with a soya based emulsion (Intralipid) in newborn infnats receiving...

Medical condition: Prematurity Parenteral nutrition

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Preterm newborn infants, Newborns, Under 18

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA)

Trial results: (No results available)

EudraCT Number: 2009-009278-29

Sponsor Protocol Number: S51477

Start Date:

Sponsor Name: UZ Leuven

Full Title: Follow-up studie: Metformin therapie bij kinderen en adolescenten met neurogene of neuromusculaire aandoeningen

Medical condition: Neuromuscular and neurological diseases, associated with obesity and insulin resistance

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10022489	Insulin resistance	LLT
	9.1		10022489	Insulin resistance	PT
	9.1		10029883	Obesity	LLT
	9.1		10065941	Central obesity	PT

Population Age: Adolescents, Under 18

Gender: Male, Female

Trial protocol: BE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2009-013956-62

Sponsor Protocol Number: DEMIJO

Start Date:

Sponsor Name: University Medical Center of the University Ulm

Full Title: Preparation of Neuroplant® 300mg N in film-coated tablets (St. John´s wort, SJW) in the treatment of mild to moderate Major Depressive Disorder (MDD) in adolescents from 12 to 17 years (inclusive):...

Medical condition: Mild to moderate MDD acc. DSM-IV-TR in adolescents (12−17years inclusive)

Disease:	Version	SOC Term	Classification Code	Term	Level
	12.0		10025453	Major depressive disorder NOS	LLT

Population Age: Adolescents, Under 18

Gender: Male, Female

Trial protocol: DE (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2009-013499-29

Sponsor Protocol Number: SUNDRO20

Start Date:

Sponsor Name: Technische Universität München

Full Title: Dosisfindungsstudie für Sugammadex und Neostigmin zur Reversierung einer geringen neuromuskulären Restblockade (train of four ratio 0,2) [Sugammadex and Neostigmine dose finding study for reversal ...

Medical condition: Dose finding study for sugammadex and/or neostigmine at residual neuromuscular blockade (whereas residual neuromuscular blockade is defined as a TOF of 0.2 in this study).

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10057286	Neuromuscular blockade reversal	LLT
	9.1		10057286	Neuromuscular blockade reversal	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

Derniers essais

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue